Physiological modeling of toxicokinetic interactions: Implications for mixture risk assessment

被引:20
作者
Haddad, S [1 ]
Krishnan, K [1 ]
机构
[1] Univ Montreal, Dept Med Travail & Hyg Milieu, Fac Med, Grp Rech Toxicol Humaine, Montreal, PQ H3T 1A8, Canada
关键词
toxic interactions; chemical mixtures; PBPK modeling; risk assessment;
D O I
10.1289/ehp.98106s61377
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Most of the available data on chemical interactions have been obtained in animal studies conducted by administering high doses of chemicals by routes and scenarios different from anticipated human exposures. A mechanistic approach potentially useful for conducting dose, scenario, species, and route extrapolations of toxic interactions is physiological modeling. This approach involves the development of mathematical descriptions of the interrelationships among the critical determinants of toxicokinetics and toxicodynamics. The mechanistic basis of the physiological modeling approach not only enables the species, dose, route, and scenario extrapolations of the occurrence of toxicokinetic interactions but also allows the extrapolation of the occurrence of interactions from binary to multichemical mixtures. Examples are presented to show the feasibility of predicting changes in toxicokinetics of the components of complex chemical mixtures based on the incorporation of binary interaction data within physiologically based models. Interactions-based mixture risk assessment can be performed by simulating the change in the tissue dose of the toxic moiety of each mixture component during combined exposures and calculating the risk associated with each tissue dose estimate using a tissue dose versus response curve for all components. The use of such a mechanistic approach should facilitate the evaluation of the magnitude and relevance of chemical interactions in assessing the risks of low-level human exposures to complex chemical mixtures.
引用
收藏
页码:1377 / 1384
页数:8
相关论文
共 31 条
[1]   PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE [J].
ANDERSEN, ME ;
CLEWELL, HJ ;
GARGAS, ML ;
SMITH, FA ;
REITZ, RH .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) :185-205
[2]   INHALATION PHARMACOKINETICS - EVALUATING SYSTEMIC EXTRACTION, TOTAL INVIVO METABOLISM, AND THE TIME COURSE OF ENZYME-INDUCTION FOR INHALED STYRENE IN RATS BASED ON ARTERIAL BLOOD - INHALED AIR CONCENTRATION RATIOS [J].
ANDERSEN, ME ;
GARGAS, ML ;
RAMSEY, JC .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1984, 73 (01) :176-187
[3]   MODELING RECEPTOR-MEDIATED PROCESSES WITH DIOXIN - IMPLICATIONS FOR PHARMACOKINETICS AND RISK ASSESSMENT [J].
ANDERSEN, ME ;
MILLS, JJ ;
GARGAS, ML ;
KEDDERIS, L ;
BIRNBAUM, LS ;
NEUBERT, D ;
GREENLEE, WF .
RISK ANALYSIS, 1993, 13 (01) :25-36
[4]   CHLOROETHYLENE MIXTURES - PHARMACOKINETIC MODELING AND IN-VITRO METABOLISM OF VINYL-CHLORIDE, TRICHLOROETHYLENE, AND TRANS-1,2-DICHLOROETHYLENE IN RAT [J].
BARTON, HA ;
CREECH, JR ;
GODIN, CS ;
RANDALL, GM ;
SECKEL, CS .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1995, 130 (02) :237-247
[5]   ZINC, COPPER AND MANGANESE IN THE ORGANS OF RATS AFTER SUBLETHAL CYANIDE INTOXICATION [J].
BEHARI, JR ;
MENGEL, K ;
FRIEDBERG, KD .
ARCHIVES OF TOXICOLOGY, 1981, 48 (01) :41-50
[6]  
Clewell H J 3rd, 1985, Toxicol Ind Health, V1, P111
[7]  
DEBETHIZY JD, 1994, PRINCIPLES METHODS T, P101
[8]  
DREISBACH RH, 1977, HDB POISONING, P241
[9]  
DUVE HG, 1972, N-S ARCH PHARMACOL S, V274, P30
[10]   Exploration of an interaction threshold for the joint toxicity of trichloroethylene and 1,1-dichloroethylene: Utilization of a PBPK model [J].
ElMasri, HA ;
Tessari, JD ;
Yang, RSH .
ARCHIVES OF TOXICOLOGY, 1996, 70 (09) :527-539